SCHEMBL13716367

SCHEMBL13716367

COC1C(CO)OC(OC(C)C)C(O)C1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AMY2A P04746 1/20 0.45
▸ TYR P14679 6/20 0.40
▸ LGALS8 O00214 2/20 0.39
▸ MGAM O43451 2/20 0.36
▸ SI P14410 2/20 0.36
▸ AMY1A P0DUB6 1/20 0.36
▸ CD209 Q9NNX6 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ PRKD3 O94806 1/20 0.36
▸ PRKCG P05129 1/20 0.36
▸ PRKCB P05771 1/20 0.36
▸ PRKCA P17252 1/20 0.36
▸ PRKCH P24723 1/20 0.36
▸ PRKCI P41743 1/20 0.36
▸ PRKCE Q02156 1/20 0.36
▸ PRKCQ Q04759 1/20 0.36
▸ PRKCZ Q05513 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16234072 1.00 AMY2A (0.45) AMY2ATYRLGALS8MGAMSI
SCHEMBL27416662 0.94 AMY2A (0.53) AMY2ATYRLGALS8MGAMSI
SCHEMBL10073936 0.94 AMY2A (0.53) AMY2ATYRLGALS8MGAMSI
SCHEMBL13713719 0.90 TYR (0.41) TYRLGALS8AMY1AL3MBTL1CA1
SCHEMBL22224178 0.90 TYR (0.41) TYRLGALS8AMY1AL3MBTL1CA1
SCHEMBL13126159 0.90 TYR (0.41) TYRLGALS8AMY1AL3MBTL1CA1
SCHEMBL15958439 0.87 AMY2A (0.47) AMY2ATYRLGALS8AMY1A
SCHEMBL13161605 0.87 LGALS8 (0.46) AMY2ATYRLGALS8MGAMSI
SCHEMBL12440685 0.87 LGALS8 (0.42) TYRLGALS8L3MBTL1CA1CA2
SCHEMBL19668934 0.87 LGALS8 (0.46) AMY2ATYRLGALS8MGAMSI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8329155-B2 Quaternary ammonium functionalized glycodendrimers, methods for the production and use thereof MONTANA STATE UNIVERSITY (US) 2012-12-11 — — US disclosed
US-20090196847-A1 QUATERNARY AMMONIUM FUNCTIONALIZED GLYCODENDRIMERS, METHODS FOR THE PRODUCTION AND USE THEREOF NIH 2009-08-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090196847-A1 QUATERNARY AMMONIUM FUNCTIONALIZED GLYCODENDRIMERS, METHODS FOR THE PRODUCTION AND USE THEREOF ZYX, FUT5, B3GNT2 AMY2A 3263/4885TYR 3883/4885LGALS8 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback